

The Future of CAR-T with Bristol Myers Squibb's Lynelle Hoch
Aug 31, 2023
Lynelle Hoch, SVP at Bristol Myers Squibb, discusses the near-term future of CAR-T therapy, innovations in the CGT sector, and Bristol Myers Squibb's plans in auto-immune diseases. Challenges in treating solid tumors and personal lives of the hosts are also explored.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 2min
Future Plans for CAR-T Cell Therapy
01:35 • 8min
Challenges and Opportunities in Cell Therapy for Solid Tumor Cancers
09:26 • 8min
Bristol Myers Squibb's Future Plans and Developments in Cell Therapy
17:37 • 4min
Admiration for Bristol Myers Squibb and Personal Lives of the Hosts
21:50 • 4min